<i>In Vitro</i> Drug Delivery Performance of a New Budesonide/Formoterol Pressurized Metered-Dose Inhaler

Abstract

Budesonide/formoterol pMDI provides a consistent delivered dose with an appropriate respirable fraction for therapeutic effectiveness. The product satisfies the performance requirements of current U.S. pharmacopeial and regulatory standards for pharmaceutical pMDI products.